3i Group has announced an investment in Royal Sanders to enhance the company's international growth and capitalize on opportunities in the personal care products market.
Target Information
Royal Sanders is a prominent European manufacturer specializing in private label and contract manufacturing of personal care products. The company operates state-of-the-art facilities located in Vlijmen, Netherlands, and Preston, UK. Royal Sanders' product portfolio includes a variety of personal care items such as shampoos, bath and shower gels, body lotions, and hand washes, catering primarily to markets in the Benelux region, Germany, and the UK. The company sells its offerings through both private labels and its own brands, including Van Gils, Sanicur, and Odorex.
Over the past decade, Royal Sanders has showcased a robust performance, achieving a compounded annual growth rate (CAGR) of 13% in sales, significantly surpassing industry averages. This success is attributed to the company's commitment to quality, the establishment of long-term relationships with key customers, and its advanced operational capabilities, making it a formidable player in the personal care sector.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The personal care products industry in Europe is characterized by strong demand driven by rising consumer awareness regarding hygiene and skincare. In recent years, there has been a noticeable shift towards private label products,
Similar Deals
APG Asset Management → Rival Foods
2025
Paine Schwartz Partners → Hendrix Genetics
2023
World Fund and CPT Capital → ENOUGH
2023
Craft Capital → Continental Shellfish Organisation
2021
3i Group plc
invested in
Royal Sanders
in 2023
in a Growth Equity & Expansion Capital deal